CTA Launches New Trustworthiness Standard for AI in Health Care

More than 60 organizations – from global tech brands to startups and health care industry leaders – convened by the Consumer Technology Association (CTA)® have developed a new ANSI-accredited standard that identifies the core requirements and baseline to determine trustworthy AI solutions in health care. This standard, part of CTA’s initiative on AI in health care, is the second in a series of standards focused on implementing medical and health care solutions built on AI.  

“AI is providing solutions – from diagnosing diseases to advanced remote care options – for some of health care’s most pressing challenges,” said Gary Shapiro, president and CEO, CTA. “As the U.S. health care system faces clinician shortages, chronic conditions and a deadly pandemic, it’s critical patients and health care professionals trust how these tools are developed and their intended uses.”

The consensus-driven standard – ANSI/CTA-2090, The Use of Artificial Intelligence in Health Care: Trustworthiness – considers three expressions of how trust is created and maintained: 

• Human Trust focuses on fostering humanistic factors that affect the creation and maintenance of trust between the developer and users. Specifically, human trust is built upon human interaction, the ability to easily explain, user experience and levels of autonomy of the AI solution. 
• Technical Trust focuses on the technical execution of the design and training of an AI system to deliver results as expected. Technical trust can also be defined by considerations for data quality and integrity including issues of bias, data security, privacy, source and access. 
• Regulatory Trust is gained through compliance by industry based upon clear laws and regulations. This trust can be based upon information from regulatory agencies, federal and state laws and accreditation boards and international standardization frameworks. 

“Establishing these pillars of trust represents a step forward in the use of AI in health care,” said Pat Baird, regulatory head of global software standards at Philips and co-chair of the working group. “AI can help caregivers spend less time with computers, and more time with patients. In order to get there, we realized that different approaches are needed to gain the trust of different populations and AI-enabled solutions need to benefit our customers, patients and society as a whole. Collaboration across the health care ecosystem is essential to establish trust.”

Membership in the CTA Artificial Intelligence in Health Care working group has doubled in less than two years and includes a wide range of decision makers from 64 organizations and member companies. The new standard joins a previous standard outlining definitions and characteristics to provide a framework to better understand AI technologies and common terminology so consumers, tech companies and care providers can better communicate, develop and use AI-based health care technologies. 

Participating organizations include:
98point6 Inc.
Activbody Inc.
AdvaMed 
Amalgam Rx
America's Health Insurance Plans 
athenahealth
b4gadget
BAND Connect 
BlackBerry 
Bohua UHD
CareMoat
CarePredict, Inc. 
Connected Health Initiative 
Diagnostikare
Duke Margolis Center for Health Policy
Federation of State Medical Boards
Ginger
GlucosoneZone by Fitscript
GR Schulz Associates 
Graphcore
Humanity Innovation Labs
Humetrix
Jones Day
Lumos Health
Matrix Advisors, LLC
MindMaze S.A. 
Oova
Osso VR
Philips  
Pretika 
Reemo 
ResMed 
Roche
SHIFT Performance Global 
The Joint Commission 
The Omega Concern  
United Spinal Association
Valencell, Inc.
Validic
Viz.ai  

To view the standard, visit CTA.tech/standards.